TCM
SPPI

Tradewinds Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Tradewinds Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-700
Closed -$2K – 739
2020
Q1 		$2K Hold
700
– – ﹤0.01% 576
2019
Q4 		$3K Buy
+700
New +$5.66K ﹤0.01% 581

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tradewinds Capital Management's SPPI Position: Q2 2020 in Review

Tradewinds Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2020, closing a stake of 700 shares — an estimated $2K sold.

Tradewinds Capital Management first reported a position in SPPI in Q4 2019 and held it in 2 quarters. The position peaked at $3K in Q4 2019. 158 funds tracked by Wall St. Rank hold SPPI as of Q2 2020.

  • Tradewinds Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Tradewinds Capital Management sold 700 Spectrum Pharmaceuticals Inc shares in Q2 2020, an estimated $2K.
  • Tradewinds Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q4 2019 and held it in 2 quarters.
  • Tradewinds Capital Management's Spectrum Pharmaceuticals Inc position peaked at $3K in Q4 2019.
  • 158 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2020.

Based on Tradewinds Capital Management's 13F filing for Q2 2020, filed 11 Aug 2020.